Acadian Asset Management
SMTI icon

Acadian Asset Management’s Sanara MedTech SMTI Stock Holding History

Acadian Asset Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,284
Closed -$29K – 2239
2025
Q4 		$29K Buy
+1,284
New +$33.2K ﹤0.01% 1861

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management's SMTI Position: Q1 2026 in Review

Acadian Asset Management sold out of Sanara MedTech (SMTI) in Q1 2026, closing a stake of 1,284 shares — an estimated $29K sold.

Acadian Asset Management first reported a position in SMTI in Q4 2025 and held it in 1 quarter. The position peaked at $29K in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Acadian Asset Management reported no remaining Sanara MedTech position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 1,284 Sanara MedTech shares in Q1 2026, an estimated $29K.
  • Acadian Asset Management first reported a position in Sanara MedTech in Q4 2025 and held it in 1 quarter.
  • Acadian Asset Management's Sanara MedTech position peaked at $29K in Q4 2025.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.